425 related articles for article (PubMed ID: 12717237)
21. Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.
Wietzke-Braun P; Braun F; Sattler B; Ramadori G; Ringe B
World J Gastroenterol; 2004 Aug; 10(15):2213-7. PubMed ID: 15259068
[TBL] [Abstract][Full Text] [Related]
22. Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation.
Takada Y; Kaido T; Asonuma K; Sakurai H; Kubo S; Kiuchi T; Inomata Y; Isaji S; Tsumura H; Teramukai S; Matsubara Y; Sakabayashi S; Uemoto S
Liver Transpl; 2013 Aug; 19(8):896-906. PubMed ID: 23696054
[TBL] [Abstract][Full Text] [Related]
23. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K
Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year.
Kato T; Gaynor JJ; Yoshida H; Montalvano M; Takahashi H; Pyrsopoulos N; Nishida S; Moon J; Selvaggi G; Levi D; Ruiz P; Schiff E; Tzakis A
Transplantation; 2007 Oct; 84(7):829-35. PubMed ID: 17984834
[TBL] [Abstract][Full Text] [Related]
25. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Farney AC
Transplant Proc; 2014; 46(6):1928-31. PubMed ID: 25131073
[TBL] [Abstract][Full Text] [Related]
26. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
[TBL] [Abstract][Full Text] [Related]
27. Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study.
Boillot O; Seket B; Dumortier J; Pittau G; Boucaud C; Bouffard Y; Scoazec JY
Liver Transpl; 2009 Nov; 15(11):1426-34. PubMed ID: 19877264
[TBL] [Abstract][Full Text] [Related]
28. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression.
Stratta RJ; Lo A; Shokouh-Amiri MH; Egidi MF; Gaber LW; Gaber AO
Transpl Int; 2003 Mar; 16(3):154-60. PubMed ID: 12664209
[TBL] [Abstract][Full Text] [Related]
29. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Doares W; Kaczmorski S; Farney AC
Expert Opin Biol Ther; 2014 Dec; 14(12):1723-30. PubMed ID: 25156622
[TBL] [Abstract][Full Text] [Related]
30. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G
Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435
[TBL] [Abstract][Full Text] [Related]
31. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
[TBL] [Abstract][Full Text] [Related]
32. Growth pre- and postimplementation of a steroid-free induction protocol in a large pediatric intestinal transplant population.
Nucci AM; Strohm S; Squires RH; Mazariegos GV; Sun Q; Sindhi R
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):601-6. PubMed ID: 21464750
[TBL] [Abstract][Full Text] [Related]
33. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
[TBL] [Abstract][Full Text] [Related]
34. Beneficial outcomes of a steroid-free regimen with thymoglobulin induction in pancreas-kidney transplantation.
Tanchanco R; Krishnamurthi V; Winans C; Wee A; Duclos A; Nurko S; Fatica R; Lard M; Poggio ED
Transplant Proc; 2008 Jun; 40(5):1551-4. PubMed ID: 18589149
[TBL] [Abstract][Full Text] [Related]
35. Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.
Cuervas-Mons V; Herrero JI; Gomez MA; González-Pinto I; Serrano T; de la Mata M; Fabregat J; Gastaca M; Bilbao I; Varo E; Sánchez-Antolín G; Rodrigo J; Espinosa MD
Clin Transplant; 2015 Aug; 29(8):667-77. PubMed ID: 25924549
[TBL] [Abstract][Full Text] [Related]
36. Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C.
Kamar N; Borde JS; Sandres-Saune K; Suc B; Barange K; Cointault O; Lavayssière L; Durand D; Izopet J; Rostaing L
Clin Transplant; 2005 Feb; 19(1):83-9. PubMed ID: 15659139
[TBL] [Abstract][Full Text] [Related]
37. Effect of Rabbit Antithymocyte Globulin on Acute and Chronic Active Antibody-Mediated Rejection After Kidney Transplantation.
Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T
Transplant Proc; 2019 Oct; 51(8):2602-2605. PubMed ID: 31324482
[TBL] [Abstract][Full Text] [Related]
38. Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation.
Castedal M; Skoglund C; Axelson C; Bennet W
Scand J Gastroenterol; 2018 Jun; 53(6):741-747. PubMed ID: 29688072
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience.
Yang JW; Wang JN; Men TY; Zhang XM; Li XD; Shen B; Li GY; Chen DD
Ann Transplant; 2014 Jun; 19():277-82. PubMed ID: 24906405
[TBL] [Abstract][Full Text] [Related]
40. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.
Rogers CC; Asipenko N; Horwedel T; Gautam S; Goldfarb-Rumyantzev AS; Pavlakis M; Johnson SR; Karp SJ; Evenson A; Khwaja K; Hanto DW; Mandelbrot DA
Am J Nephrol; 2013; 38(5):397-404. PubMed ID: 24192457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
